Compass Point analyst Rommel Dionisio lowered his revenue and earnings estimates for Tilray and cut his price target on the shares to $38 from $41 after the Canadian government issued a press release Friday that he said effectively delays the introduction of advanced forms of cannabis until at least mid-December 2019, at the earliest. Licensed cannabis companies must give Health Canada 60-days notice of their intent to sell products such as vapes, beverages, or edibles, but the government will not be accepting any such applications until Oct. 17, noted Dionisio, who keeps a Neutral rating on Tilray shares.

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on study dosing, a completed acquisition and a research partnership. ATAI ANNOUNCES DOSING... To see the rest of the story go to thefly.com. See Story Here

Tilray Brands celebrated 420 with an unprecedented display of community and craftsmanship, with over 20,000 guests attending Tilray's 420 weekend events of vibrant festivals and environmental advocacy. "As a company, we recognize the cultural significance of 420 and its impact on the cannabis industry. By celebrating this day across our brands, we not only honor the traditions of our consumers but also continue to push the boundaries of innovation and progress across both cannabis and craft beer industries," said Irwin Simon, Chairman and CEO, Tilray Brands. "Tilray Brands will continue to connect with consumers across the U.S. and international markets through more festivals, concerts, and events that bring together our passionate community. We will continue to collaborate with like-minded partners who share our values and vision and work towards creating meaningful experiences that are fun and that empower our consumers."